Full Text View
Tabular View
No Study Results Posted
Related Studies
Testosterone and Myocardial Perfusion in CHD
This study has been completed.
Study NCT00239590   Information provided by Imperial College London

First Received on October 13, 2005.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Heart Disease
Additional conditions recognized in this trial
Coronary Artery Disease
Coronary Disease
Heart Diseases
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Testosterone undecanoate
Additional drug interventions recognized in this trial
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Imperial College London
Organon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services